Showing results (21-30 of 746) with videos related to
Sort By:
Pageof 75
The Clinical Investigator|December 1, 1994
Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glandsT Jeck, B Weisser, T Mengden, et al.Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|June 2, 1992
[Acceptance of 24-hour blood pressure determination]B Binswanger, B Weisser, T Mengden, et al.International Journal of Clinical Pharmacology Research|January 1, 1992
Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprololT Jeck, D Edmonds, T Mengden, et al.European Journal of Clinical Pharmacology|January 1, 1992
Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprololT Mengden, B Bättig, M Schubert, et al.Biochemical and Biophysical Research Communications|May 14, 1993
Low density lipoprotein subfractions increase thromboxane formation in endothelial cellsB Weisser, R Locher, J de Graaf, et al.Deutsche Medizinische Wochenschrift (1946)|March 14, 2003
[Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives]B Weisser, H Vetter, T MengdenBiochemical and Biophysical Research Communications|April 30, 1993
Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from ratA Sachinidis, Y Ko, A Wieczorek, et al.Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|August 2, 1990
[Peroneal weakness]T Mengden, A Hermann, W VetterBlood Pressure|May 13, 1999
Changes in antihypertensive therapy--the role of adverse effects and complianceR Düsing, B Weisser, T Mengden, et al.Drug Safety|March 1, 1991
A comparative review of the adverse effects of treatments for hyperlipidaemiaA Steiner, B Weisser, W VetterPageof 75